TABLE 1.
Costs and probabilities of type 2 diabetes-related complications used in the economic model.
| Complications | Value/patient/year (US$) | Source of data (Ref.) |
|---|---|---|
| Costs | ||
| Cardiovascular disease | 1,529.00 | Rosa et al. (2018) |
| Retinopathy | 621.00 | Bahia et al. (2019) |
| Nephropathy | 1,602.00 | Bahia et al. (2019) |
| Hospitalization | 3,917.00 | Henriques et al. (2018) |
| Diabetic foot with healing a | 162.10 | Rezende et al. (2008) |
| Diabetic foot with minor amputation a | 112.90 | Rezende et al. (2008) |
| Diabetic food with major amputation a | 223.80 | Rezende et al. (2008) |
| Diabetes general cost | 1,844.00 | Borges et al. (2014) |
| Probability of occurrence | ||
| Cardiovascular disease | 0.129 | Santos et al. (2015) |
| Retinopathy | 0.1340 | Henriques et al. (2018) |
| Nephropathy | 0.1680 | Henriques et al. (2018) |
| Hospitalization | 0.1895 | Li et al. (2018) |
| Diabetic foot | 0.0310 | Bao et al. (2017) |
| Probability of death | ||
| Cardiovascular disease | 0.2840 | Bujang et al. (2018) |
| Retinopathy | 0.0000 | Schmidt et al. (2015) |
| Nephropathy | 0.0381 | Sinkeler et al. (2013) |
| Hospitalization | 0.0617 | Li et al. (2018) |
| Diabetic foot | 0.0740 | Vassallo et al. (2019) |
a
Values converted to USD according to the currency exchange on 07/26/2019 and updated to 2020 values, according to the World Bank annual deflator data.